Genotypic comparison of Pantoea agglomeransplant and clinical strains
© Rezzonico et al; licensee BioMed Central Ltd. 2009
Received: 29 April 2009
Accepted: 22 September 2009
Published: 22 September 2009
Pantoea agglomerans strains are among the most promising biocontrol agents for a variety of bacterial and fungal plant diseases, particularly fire blight of apple and pear. However, commercial registration of P. agglomerans biocontrol products is hampered because this species is currently listed as a biosafety level 2 (BL2) organism due to clinical reports as an opportunistic human pathogen. This study compares plant-origin and clinical strains in a search for discriminating genotypic/phenotypic markers using multi-locus phylogenetic analysis and fluorescent amplified fragment length polymorphisms (fAFLP) fingerprinting.
Majority of the clinical isolates from culture collections were found to be improperly designated as P. agglomerans after sequence analysis. The frequent taxonomic rearrangements underwent by the Enterobacter agglomerans/Erwinia herbicola complex may be a major problem in assessing clinical associations within P. agglomerans. In the P. agglomerans sensu stricto (in the stricter sense) group, there was no discrete clustering of clinical/biocontrol strains and no marker was identified that was uniquely associated to clinical strains. A putative biocontrol-specific fAFLP marker was identified only in biocontrol strains. The partial ORF located in this band corresponded to an ABC transporter that was found in all P. agglomerans strains.
Taxonomic mischaracterization was identified as a major problem with P. agglomerans, and current techniques removed a majority of clinical strains from this species. Although clear discrimination between P. agglomerans plant and clinical strains was not obtained with phylogenetic analysis, a single marker characteristic of biocontrol strains was identified which may be of use in strain biosafety determinations. In addition, the lack of Koch's postulate fulfilment, rare retention of clinical strains for subsequent confirmation, and the polymicrobial nature of P. agglomerans clinical reports should be considered in biosafety assessment of beneficial strains in this species.
Pantoea agglomerans (Beijerinck 1888) comb. nov. , formerly Enterobacter agglomerans (Beijerinck 1888) Ewing and Fife (1972), Erwinia herbicola (Löhnis 1911) Dye 1964 or Erwinia milletiae (Kawakami and Yoshida 1920) Magrou 1937, is a Gram-negative bacterium that belongs to the family of Enterobacteriaceae. P. agglomerans is primarily a plant epiphyte [2–4] commonly found in diverse ecological niches including aquatic environments, soil or sediments [5–7]. Several strains of P. agglomerans are sold as commercial biological control agents (BCAs) against the fire blight pathogen [Erwinia amylovora (Burrill 1882) Winslow et al. 1999] on apple and pear trees [8, 9]. P. agglomerans strains are effective against other bacterioses, such as basal kernel blight of barley  and post-harvest fungal diseases of pome fruits [11–14]. Three commercial P. agglomerans strains have recently been registered for biocontrol of fire blight in New Zealand (BlossomBless™ strain P10c ), in the United States and in Canada (BlightBan C9-1™ strain C9-1 ; Bloomtime™ strain E325 ). The primary mode of action is competitive exclusion which involves the occupation of sites otherwise colonized by the pathogen, but for some strains reports also indicate the contribution of different antibiotics like herbicolins  pantocins [18–21], putatively phenazine , and other unknown compounds .
Despite efficacy trials in commercial orchards demonstrating the potential of P. agglomerans biocontrol formulations as an alternative plant protection tool and their approval in the United States by the Environmental Protection Agency (EPA) as microbial pesticides http://www.epa.gov/fedrgstr/EPA-PEST/2006/September/Day-20/p8005.htm, registration efforts in Europe are hindered by biosafety concerns stemming from clinical reports that identify strains of P. agglomerans as opportunistic human pathogens, and have resulted in the current classification of this species as a biosafety level 2 (BL-2) organism in Europe [23–27]. Biosafety classification differs among countries; in the European Union, Directive 2000/54/EC includes "Enterobacter spp." in the list of microorganisms that are currently classified as a biosafety level 2 (BL-2), while the German "Technische Regeln für Biologische Arbeitsstoffe", TRBA 466 and Swiss regulations http://www.bafu.admin.ch/publikationen/publikation/00594/index.html?lang=de more explicitly identify P. agglomerans and its synonyms in BL-2. Several strains maintained in culture collections throughout the world and the type strain P. agglomerans LMG 1286T (= CDC 1461-61T = NCTC 9381T = ICMP 3435T = ATCC 27155T) itself are listed as clinical isolates . Confirmed pathogenicity of this species is difficult to ascertain, since clinical reports involving P. agglomerans are typically of polymicrobial nature, often involve patients that are already affected by diseases of other origin, lack Koch's postulate fulfillment or any pathogenicity confirmation, and diagnostic isolates are rarely conserved for confirmatory analysis .
There has been insufficient investigations as to whether agriculturally beneficial isolates are distinct from clinical isolates or harbor potential pathogenic determinants that would justify current biosafety restrictions. Comparative analysis of biocontrol and clinical strains, or examination of virulence factors has been performed previously for other 'Jekyll-Hyde' biocontrol species reported to contain opportunistic pathogenic isolates, such as Pseudomonas aeruginosa [28–30], Serratia marcescens  and the Burkholderia cepacia complex [32, 33]. Similar comparisons have not been performed for P. agglomerans, leaving a gap in knowledge critical to regulatory authorities.
The aim of our study was to perform a polyphasic genotypic and phenotypic analysis of P. agglomerans isolates of diverse origin in order to understand whether clinical and biocontrol (environmental) isolates can be distinguished and have undergone a discrete evolution that would indicate specialization towards human pathogenicity or an epiphytic lifestyle. The taxonomy of a collection of clinical and plant isolates was assessed using fluorescent amplified fragment length polymorphism (fAFLP) analysis of total genomic DNA and sequence analyses of specific genes (such as 16S rDNA gene rrs, gyrB encoding DNA gyrase subunit B, and the P. agglomerans quorum-sensing regulatory genes pagRI encoding homoserine lactone receptor and synthase) . The fAFLP analysis was used as well to search for random molecular markers that could serve as a simple and rapid discriminatory marker for clinical and biocontrol strains. Additionally, we examined the distribution of some phenotypic and genotypic traits among strains that may reflect adaptation to the different lifestyles proposed for P. agglomerans, such as growth at 37°C for clinical isolates, presence of pantocin A genes or sorbitol utilization for biocontrol strains, and presence of type III secretion system (T3SS) for plant pathogenic pathovars.
Thirty-two clinical isolates designated as P. agglomerans, E. agglomerans, E. herbicola or Pantoea spp. were obtained from the American Type Culture Collection (ATCC, http://www.atcc.org/), the Belgian Coordinated Collection of Microorganisms (BCCM/LMG, http://bccm.belspo.be), the Institut Pasteur Collection (CIP, http://www.crbip.pasteur.fr/), the Spanish Type Culture Collection (CECT, http://www.cect.org/) or received from the Hospital de la Santa Crei Sant Pau (Barcelona, Spain) and the Istituto Cantonale di Microbiologia (ICM, Bellinzona, Switzerland). Eleven P. agglomerans strains with established biocontrol activity obtained from several sources (including the three currently registered commercial strains), twenty environmental isolates and three phytopathogenic strains, together with representative strains of other Pantoea species and closely related genera such as Erwinia, Pectobacterium and Brenneria, were included in the study for comparison (see Additional file 1 - Table S1).
DNA extraction and PCR amplification
PCR primers used for gene amplification and sequencing.
Sequencing of 16S rDNA, gyrB and pagRI genes
PCR amplicons were purified from the PCR mix by washing twice with 50 μl of double-distilled water (ddH2O) on a MultiScreen PCR Plate (Millipore, Molsheim, France), resuspended in 30 μl of ddH2O, and quantified spectrophotometrically as described above. The cycle-sequencing reaction was performed with 20-40 ng of purified PCR product using the ABI PRISM BigDye Terminators v1.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, U.S.A.) according to the manufacturer instructions employing the same primers used for PCR amplification. For 16S rRNA gene sequencing, additional primers 16S-609R and 16S-533R (Table 1) were used to obtain complete coverage of the amplicon. Cycle sequencing products were cleaned through water-swelled Sephadex G-50 columns (Amersham Biosciences, Uppsala, Sweden) on MultiScreen HV plates (Millipore) and sequenced on an ABI PRISM 3100 Genetic Analyzer. Obtained sequences were assembled using the Sequencher software (version 4.0.5; Gene Codes Corporation, Ann Arbor, MI, U.S.A.).
Phylogenetic analysis of sequencing data
Phylogenetic trees were generated on the basis of partial 16S rDNA, gyrB and pagRI sequences without choosing any outgroup. DNA sequences were aligned with ClustalW . Sites presenting alignment gaps were excluded from analysis. The Molecular Evolutionary Genetics Analysis (MEGA) program version 4.0  was used to calculate evolutionary distances and to infer trees based on the Minimum Evolution (ME) method using the Maximum Composite Likelihood (MCL) formula. Nodal robustness of the inferred trees was assessed by 1000-bootstrap replicates.
Identification of non-Pantoea strains
For those strains received as E. agglomerans, P. agglomerans or Pantoea spp. from international culture collections but not clustering with P. agglomerans in the 16S rDNA and gyrB trees, identification was sought by blasting the obtained nucleotide sequences in the NCBI database. Since the best hits often led to poorly characterized or obviously misdentified bacteria only the best match with a secure identification was retained. Confidence of secure identifications was based either on relatedness to the P. agglomerans type strain or position in the BLAST distance tree. In order to be considered trustworthy, obtained hits were required to be flanked by sequences of representatives of the same species and not be part of a clade containing strains from related species with dissimilar identification.
Primers combinations and number of different peak positions generated used in the selective amplification step.
Analysis of fAFLP data
Raw data collected from the ABI 3130XL sequencer were analyzed using the GeneMapper v4.0 software (Applied Biosystems). To remove noise, only peaks with an absolute intensity greater than 200 (combinations CGC, TG) or 300 (combinations GG, AT) were retained for final analysis. The fAFLP profiles were converted into a binary matrix of presence/absence of each peak and this data was used to construct a UPGMA (Unweighted Pair Group Method with Arithmetic mean) dendrogram using the MEGA software. Nodal robustness of the inferred trees was assessed by 1000-bootstrap replicates. The fAFLP patterns of all strains were analyzed in order to identify peaks that may be distinctive of either biocontrol or clinical isolates in agreement with the classification shown in Additional file 1 - Table S1.
Growth on sorbitol as sole carbon source
Growth ability of P. agglomerans strains on sorbitol was studied using 200-μl microcultures in 100-well Bioscreen C MBR system honeycomb plates (well volume 400 μl) at 24°C with regular shaking at 15-min intervals in M9 minimal medium containing 10 mM sorbitol as sole carbon source. All strains were grown overnight in LB, collected by centrifugation, and washed twice with sterile 0.9% NaCl before being inoculated in M9 at an initial OD600 of about 0.02. Growth curves were measured in triplicates by periodically quantifying the absorbance through a 420- to 580-nm wide band filter (OD420-580 nm) using a Bioscreen C MBR system (Growth Curves Oy, Helsinki, Finland).
Growth at 24°C and 37°C
where N0 and N t represent absorbance measured at two consecutive time points and Δt is the time interval (i.e., 1 h) between the two measurements. The highest optical density, the maximal growth rate, as well as the time needed to reach the latter value were recorded for each strain. A comparison of these parameters was performed among the average values obtained for clinical, biocontrol or plant-pathogenic P. agglomerans strains. Correlations between OD420-580 nm measured in the Bioscreen C MBR system and number of colony forming unit (CFU) was estimated for representative strains by dilution plating on LB agar.
The accession numbers for the sequences produced for this study are: 16S rRNA gene [GenBank: FJ611802-FJ611887]; gyrB gene [GenBank: FJ617346-FJ617427]; hrcN gene [GenBank: FJ617428-FJ617436]; pagRI genes [GenBank: FJ656221-FJ656252].
With the exception of pagRI, for which they are shown directly in the corresponding figure, accession numbers and other sources of reference sequences not obtained in this work are indicated below. Complete genomes: C. koseri ATCC BAA-895 [NCBI: NC_009792], E. amylovora Ea273 http://www.sanger.ac.uk/Projects/E_amylovora/, E. coli K-12 MG1655 [NCBI: NC_000913], Enterobacter sp. 638 [NCBI: NC_009436], E. tasmaniensis Et1/99 [NCBI: NC_010694], K. pneumoniae 342 [NCBI: NC_011283], P. stewartii subsp. indologenes DC283 http://www.hgsc.bcm.tmc.edu/microbial-detail.xsp?project_id=125. 16S rRNA gene: E. cloacae ATCC 13047T [GenBank: AJ251469], E. sakazakii ATCC 51329 [GenBank: AY752937], Pantoea sp. LMG 2558 [GenBank: EF688010], Pantoea sp. LMG 2781 [GenBank: EU216736], Pantoea sp. LMG 24198 [GenBank: EF688009], Pantoea sp. LMG 24199 [GenBank: EF688012], Pantoea sp. LMG 24200 [GenBank: EF688011], Pantoea sp. LMG 24534 [GenBank: EU216737], P. terrea LMG 22051T [GenBank: EF688007], S. enterica sv typhi CT18 [NCBI: NC_003198]. gyrB gene: E. cloacae ATCC 13047T [GenBank:EU643470], E. sakazakii ATCC 51329 [GenBank:AY370844], Pantoea sp. BD502 [GenBank: EF988786], Pantoea sp. BCC757 [GenBank: EF988776], Pantoea sp. LMG 2558 [GenBank: EF988812], Pantoea sp. LMG 2781 [GenBank:EU145271], Pantoea sp. LMG 24196 [GenBank: EF988758], Pantoea sp. LMG 24199 [GenBank: EF988768], Pantoea sp. LMG 24200 [GenBank: EF988770], Pantoea sp. LMG 24202 [GenBank: EF988778], Pantoea sp. LMG 24534 [GenBank: EU145269], P. terrea LMG 22051T [GenBank:EF988804], S. enterica sv typhi CT18 [NCBI: NC_003198].
PCR amplification and sequencing of 16S rDNA, gyrB and pagRI genes
Taxonomy of clinical and biocontrol P. agglomerans isolates
Sequence analysis of gyrB revealed that 26 of the 32 clinical isolates obtained from international culture collections as P. agglomerans, E. agglomerans or Pantoea spp. did not justifiably belong to P. agglomerans, but clustered distant from type strain LMG 1286T. Based on genotypic similarity, these strains belonged either to other Pantoea spp. or other Enterobacteriaceae genera. In contrast, classification of biocontrol strains was more precise than for presumptively clinical strains, and all of these could be identified unequivocally as P. agglomerans sensu stricto (Figure 2).
Congruence between phylogenies derived from rrs (Figure 1) and gyrB (Figure 2) gene sequences was imperfect. Analysis using 16S rDNA enabled only limited separation of strains within each Pantoea spp., whereas analysis using gyrB sequences revealed higher variability and enabled finer resolution of distinct branches with some strains clustering alongside P. agglomerans LMG 1286T in the rrs tree. The gyrB clades corresponded largely to the MLST-groups recently defined by Brady et al.  for Pantoea spp. (Figure 2).
Four strains (EM13cb, EM17cb, ATCC 29001 and SC-1) that grouped with representative strains of Pantoea MLST-groups C, D and F in the rrs tree clearly diverged using gyrB sequences. Clinical isolate EM13cb and cotton pathogen SC-1 clustered with LMG 2558 (MLST-group C), while two other clinical isolates, EM17cb and ATCC 29001, clustered with LMG 24534 (MLST-group F) and LMG 5343 (MLST-group E) using either rrs or gyrB. In contrast, LMG 5343, LMG 24198 (MLST-group B) and LMG 24199 (MLST-group A), all clustered unexpectedly with P. agglomerans in the rrs tree (Figure 1) but were clearly divergent using gyrB. This demonstrated the resolution limits of 16S rDNA sequence analysis among Pantoea spp. Both rrs and gyrB sequences assigned two additional presumptive-clinical strains (ATCC 27995 and ATCC 27996) to the related species Pantoea ananatis (Serrano 1928) Mergaert et al. 1993, while most of the other human isolates (including representatives from Brenner's biotypes VII-XII ) clustered far from the P. agglomerans sensu stricto group and could be roughly assigned to Erwinia or Enterobacter spp. (see Additional file 2 - Table S2) based on BLAST comparison. Indicative of the uncertainty surrounding identification of this species, the BLAST best-hits list often included isolates clearly misidentified as P. agglomerans or Pantoea spp. Specifically, strains with extremely low sequence similarity with the P. agglomerans type strain LMG 1286T (well below 90%) were interspersed among better characterized Enterobacteriaceae.
Two plant epiphytic isolates (EPS486 and EPS595) from apple and pear trees and two wheat root isolates (P8SAA and P10QLC) formed a clearly distinct group in both trees which is not embraced by any of the MLST-groups defined for Pantoea , and are considered representative of a single new Pantoea spp.
fAFLP of P. agglomerans sensu stricto isolates
Comparison of other genotypic and phenotypic traits
Utilization of sorbitol by P. agglomerans as a sole carbon source was restricted to only a few biocontrol isolates, indicating this as an important feature for phytopathogen antagonism. In addition to the commercial biocontrol strain C9-1, which has two plasmid-encoded sorbitol-utilization operons , only the biocontrol strains Eh252 and P10c were able to efficiently metabolize sorbitol. Strain P. ananatis LMG 2665T, included as a positive control for sorbitol utilization, and P. agglomerans strains C9-1 and Eh252 gave absorbance readings that indicated a growth after 6-8 h from inoculation, while the lag-phase of P10c was protracted up to 24 h, suggesting that a certain signal may be required for this strain before C6-sugar metabolism is triggered.
Pantocin A biosynthetic genes were amplified in just four biocontrol isolates (i.e., C9-1, Eh252, Eh318 and CPA-2) and one clinical strain LMG 5343. Genome sequence analysis of C9-1 has revealed that in this strain the gene cluster coding for pantocine production is situated on a low-GC genomic island of about 29 kbp inserted between the mutS and narL genes, which was probably acquired by horizontal gene transfer . Using primers narL-rev and mutS-rev, designed on the flanking regions of the insertion site, a 554-bp fragment could be amplified in all P. agglomerans strains that were negative for paaABC (i.e., with no genomic island insertion). The large size of the genomic island in paaABC-positive strains prevented recovery of a PCR-product amplicon. This indicates that the insertion site of the pantocin genomic island is the same as in C9-1 for all Pantoea strains carrying the pantocin A genes. The origin of the pantocin genes remains unknown, and no near or distant homologues have been identified in any other organism after an extensive BLAST search.
Discrimination of clinical and plant-associated isolates of P. agglomerans has important implications for the registration of biocontrol products for plant protection. We conducted a polyphasic genotypic analysis of a collection of strains from different ecological niches. Our first observation was that a majority of clinical strains were in fact not true P. agglomerans as defined by Gavini et al.  based on taxonomic discrepencies revealed by sequence analysis of the 16S rDNA and gyrB genes. All biocontrol strains in the collection were found to be correctly identified as P. agglomerans. The reason for this discrepancy is ascribed to the fact that bacteria selected for their biological control properties are typically better characterized, including DNA sequencing, in comparison to those obtained in clinical diagnostics where rapid identification for implementation of therapeutic treatment is the primary concern and relies on less precise biochemical identification methods (e.g., API20E and Vitek-2 from bioMerieux or Phoenix from BD Diagnostic Systems). Biochemical methods have previously been shown to misidentify P. agglomerans and Enterobacter spp. [43, 46–49], which our results confirm. Additionally, many archival strains were deposited in culture collections more than 30 years ago when the genus Pantoea was not yet taxonomically established and biochemical identification was less accurate.
We identified a single discriminatory marker for biocontrol strains using fAFLP which may be of use in biosafety decisions for registration of beneficial isolates. Only biocontrol isolates had this fAFLP band, eventhough all strains of P. agglomerans sensu stricto have indication of the gene found within the band. For differentiation purposes this is irrelevant since the purpose is to identify a genomic marker, not a specific gene.
Our polyphasic analysis indicated that clinical and biocontrol strains co-cluster within P. agglomerans sensu stricto. This suggests that both isolates from clinical and environmental habitats have undergone indistinguishable evolutionary changes and that there is no discernable specialization of clinical isolates toward human pathogenicity or biocontrol isolates toward a plant-associated life-style. We observed no evidence, but can not exclude, the possibility that clinical isolates may have acquired specific pathogenicity factors beyond T3SS on plasmids or other mobile elements, as has been reported for phytopathogenic strains [44, 45]. The T3SS discovered in some strains, however, was found to be more closely related to that in biocontrol Pseudomonas spp. indicating a non-pathogenic function . Furthermore, only one clinical isolate had a T3SS gene compared to six environmental isolates. Comparison between the completed genome of biocontrol strain C9-1 and the in progress genome sequencing of the clinical type strain of P. agglomerans LMG 1286T (T.H.M. Smits, B. Duffy et al., unpublished data) indicates that several features including antibiotic production (revealed by the presence of paaABC genes ), and nectar sugar utilization as a sole carbon source are generally associated with antagonistic activity. Our results demonstrate, however, that while many biocontrol strains have such traits, not all do and thus these are not universal features of biocontrol potential. Also, we have demonstrated for the first time the presence of the antibiotic biosynthetic genes paaABC in clinical strains, indicating that these may not be unique signatures of biocontrol isolates. What if any role pantocin may contribute to animal associations remains to be determined. There was no difference in growth at 37°C between clinical and biocontrol isolates, with both types of strains growing poorly at this temperature compared to growth at 27°C, and reinforcing the weakness of this criteria to determine pathogenicity.
Returning to the fundamental problem of insufficient confidence in identification procedures, we have shown that specific gene sequences (such as gyrB rather than 16S rDNA) are more robust than biochemical identification regarding P. agglomerans. The several reports of P. agglomerans from clinical literature upon which biosafety decisions have been based all lack a clear establishment of this species as a primary and singular cause of disease. With rare exception such isolates are not available for precise taxonomic confirmation and detailed clinical histories are typically absent for individual strains. We conducted a small survey of three clinical diagnostic laboratories in Switzerland and found that P. agglomerans is infrequently recovered. P. agglomerans was identified, predominantly as a polymicrobial co-isolate in patients, 21 times in the last four years at the ICM in Bellinzona (M. Tonolla, personal communication) and six times in the last three years at the Kantonsspital Lucerne (M. Hombach, personal communication). At the Institute for Medical Microbiology of Zürich University several strains identified as Pantoea were reported to be present in the collection of clinical samples, but no genetic sequence related to P. agglomerans was retrieved from their sequence database (G. Bloemberg, personal communication). Thus, P. agglomerans correctly characterized appears to be a more infrequent clinical organism than literature indicates.
Our study indicates that current restrictions on registration of microbial pesticides based on P. agglomerans biocontrol strains in Europe warrant review. The primary argument for biosafety concerns is not supported by the fact that a majority of clinical strains are currently misclassified as P. agglomerans as determined by sequence analysis of 16S rDNA and gyrB. Further analysis of specific genes and fAFLP patterns also distinguish beneficial from clinical strains within P. agglomerans sensu stricto. Moreover, the lack of pathogenicity confirmatory tests with clinical strains (i.e., Koch's postulates) and the polymicrobial nature in clinical reports, which is probably just a reflection of the natural abundance of this species in the environment, draws into question the biosafety concerns with plant beneficial isolates.
The authors are grateful to P. Coll (Hospital de la Santa Crei Sant Pau, Barcelona, Spain), A. Bonaterra (University of Girona, Spain) and M. Tonolla (ICM Bellinzona, Switzerland) for providing some of the strains used in this study, S. Barnett for providing DNA of Australian strains, and C. Pelludat (ACW) for helpful discussion. Financial support was provided by the Swiss Federal Secretariat for Education and Research (SBF C06.0069), the Swiss Federal Office of the Environment (BAFU), and the Swiss Federal Office of Agriculture (BLW Fire Blight Control Project). This work was conducted within the European Science Foundation funded research network COST Action 873 'Bacterial diseases of stone fruits and nuts'.
- Gavini F, Mergaert J, Beji A, Mielcarek C, Izard D, Kersters K, De Ley J: Transfer of Enterobacter agglomerans (Beijerinck 1888) Ewing and Fife 1972 to Pantoea gen. nov. as Pantoea agglomerans comb. nov. and description of Pantoea dispersa sp. nov. Int J Syst Bacteriol. 1989, 39 (3): 337-345.View ArticleGoogle Scholar
- Grimont PAD, Grimont F: Bergey's Manual of Systematic Bacteriology: Volume Two: The Proteobacteria, Part B - The Gammaproteobacteria. 2005, New York: Springer, 2: 2Google Scholar
- Lindow SE, Brandl MT: Microbiology of the Phyllosphere. Applied and environmental microbiology. 2003, 69: 1875-1883. 10.1128/AEM.69.4.1875-1883.2003.PubMed CentralPubMedView ArticleGoogle Scholar
- Andrews JH, Harris RF: The ecology and biogeography of microorganisms on plant surfaces. Ann Rev Phytopathol. 2000, 38: 145-180. 10.1146/annurev.phyto.38.1.145.View ArticleGoogle Scholar
- Laitinen S, Linnainmaa M, Laitinen J, Kiviranta H, Reiman M, Liesivuori J: Endotoxins and IgG antibodies as indicators of occupational exposure to the microbial contaminants of metal-working fluids. International Archives of Occupational and Environmental Health. 1999, 72: 443-450. 10.1007/s004200050397.PubMedView ArticleGoogle Scholar
- Brown BJ, Leff LG: Comparison of fatty acid methyl ester analysis with the use of API 20E and NFT strips for identification of aquatic bacteria. Applied Environmental Microbiology. 1996, 62 (6): 2183-2185.PubMed CentralPubMedGoogle Scholar
- Francis CA, Obraztsova AY, Tebo BM: Dissimilatory metal reduction by the facultative anaerobe Pantoea agglomerans SP1. Applied and environmental microbiology. 2000, 66 (2): 543-548. 10.1128/AEM.66.2.543-548.2000.PubMed CentralPubMedView ArticleGoogle Scholar
- Wodzinski RS, Umholtz TE, Beer SV: Mechanisms of inhibition of E. amylovora by E. herbicola in vitro and in vivo. J Appl Bacteriol. 1994, 76: 22-29.View ArticleGoogle Scholar
- Johnson KB, Stockwell VO: Management of fire blight: a case study in microbial ecology. Annu Rev Phytopathol. 1998, 36: 227-248. 10.1146/annurev.phyto.36.1.227.PubMedView ArticleGoogle Scholar
- Braun-Kiewnick A, Jacobsen BJ, Sands DC: Biological control of Pseudomonas syringae pv. syringae, the causative agent of basal kernel blight of barley, by antagonistic Pantoea agglomerans. Phytopathology. 2000, 90: 368-375. 10.1094/PHYTO.2000.90.4.368.PubMedView ArticleGoogle Scholar
- Nunes C, Usall J, Teixidó N, Fons E, Viñas I: Post-harvest biological control by Pantoea agglomerans (CPA-2) on Golden Delicious apples. J Appl Microbiol. 2002, 92: 247-255. 10.1046/j.1365-2672.2002.01524.x.PubMedView ArticleGoogle Scholar
- Bonaterra A, Camps J, Montesinos E: Osmotically induced trehalose and glycine betaine accumulation improves tolerance to dessication, survival and efficacy of the postharvest biocontrol agent Pantoea agglomerans EPS125. FEMS Microbiol Lett. 2005, 250: 1-8. 10.1016/j.femsle.2005.06.028.PubMedView ArticleGoogle Scholar
- Bonaterra A, Mari M, Casalini L, Montesinos E: Biological control of Monilinia laxa and Rhizopus stolonifer in postharvest of stone fruit by Pantoea agglomerans EPS125 and putative mechanisms of antagonism. Int J Food Microbiol. 2003, 84: 93-104.PubMedView ArticleGoogle Scholar
- Francés J, Bonaterra A, Moreno MC, Cabrefiga J, Badosa E, Montesinos E: Pathogen aggressiveness and postharvest biocontrol efficiency in Pantoea agglomerans. Postharvest Biol Technol. 2006, 39 (3): 299-307. 10.1016/j.postharvbio.2005.11.002.View ArticleGoogle Scholar
- Vanneste JL, Cornish DC, Yu J, Voyle MD: P10c: a new biological control agent for control of fire blight which can be sprayed or distributed using honey bees. Acta Hortic. 2002, 590: 231-235.View ArticleGoogle Scholar
- Ishimaru CA, Klos EJ, Brubaker RR: Multiple antibiotic production by Erwinia herbicola. Phytopathology. 1988, 78: 746-750. 10.1094/Phyto-78-746.View ArticleGoogle Scholar
- Pusey PL, Stockwell VO, Rudell DR: Antibiosis and acidification by Pantoea agglomerans strain E325 may contribute to suppression of Erwinia amylovora. Phytopathology. 2008, 98 (10): 1136-1143. 10.1094/PHYTO-98-10-1136.PubMedView ArticleGoogle Scholar
- Stockwell VO, Johnson KB, Sugar D, Loper JE: Antibiosis contributes to biological control of fire blight by Pantoea agglomerans strain Eh252 in orchards. Phytopathology. 2002, 92 (11): 1202-1209. 10.1094/PHYTO.2002.92.11.1202.PubMedView ArticleGoogle Scholar
- Vanneste JL, Yu J, Cornish DA: Presence of genes homologous to those necessary for synthesis of microcin MccEh252 in strains of Pantoea agglomerans. Acta Hort. 2008, 793: 391-396.View ArticleGoogle Scholar
- Brady SF, Wright SA, Lee JC, Sutton AE, Zumoff CH, Wodzinski RS, Beer SV, Clardy J: Pantocin B, an antibiotic from Erwinia herbicola discovered by heterologous expression of cloned genes. J Am Chem Soc. 1999, 121 (50): 11912-11913. 10.1021/ja992790m.View ArticleGoogle Scholar
- Wright SAI, Zumoff CH, Schneider L, Beer SV: Pantoea agglomerans strain EH318 produces two antibiotics that inhibit Erwinia amylovora in vitro. Applied and environmental microbiology. 2001, 67 (1): 284-292. 10.1128/AEM.67.1.284-292.2001.PubMed CentralPubMedView ArticleGoogle Scholar
- Giddens SR, Feng Y, Mahanty HK: Characterization of a novel phenazine antibiotic gene cluster in Erwinia herbicola Eh1087. Mol Microbiol. 2002, 45 (3): 769-783. 10.1046/j.1365-2958.2002.03048.x.PubMedView ArticleGoogle Scholar
- Van Rostenberghe H, Noraida R, Wan Pauzi WI, Habsah H, Zeehaida M, Rosliza AR, Fatimah I, Nik Sharimah NY, Maimunah H: The clinical picture of neonatal infection with Pantoea species. Jpn J Infect Dis. 2006, 59: 120-121.PubMedGoogle Scholar
- Cruz AT, Cazacu AC, Allen CH: Pantoea agglomerans, a plant pathogen causing human disease. J Clin Microbiol. 2007, 45 (6): 1989-1992. 10.1128/JCM.00632-07.PubMed CentralPubMedView ArticleGoogle Scholar
- Kratz A, Greenberg D, Barki Y, Cohen E, Lifshitz M: Pantoea agglomerans as a cause of septic arthritis after palm tree thorn injury; case report and literature review. Arch Dis Child. 2003, 88: 542-544. 10.1136/adc.88.6.542.PubMed CentralPubMedView ArticleGoogle Scholar
- Geere JW: Enterobacter agglomerans: the clinically important plant pathogen. Can Med Assoc J. 1977, 116: 517-519.PubMed CentralPubMedGoogle Scholar
- Bergman KA, Arends JP, Schölvinck EH: Pantoea agglomerans septicemia in three newborn infants. Pediatr Infect Dis J. 2007, 453-454. 26
- Ruimy R, Genauzeau E, Barnabe C, Beaulieu A, Tibayrenc M, Andremont A: Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect Immun. 2001, 69: 584-588. 10.1128/IAI.69.1.584-588.2001.PubMed CentralPubMedView ArticleGoogle Scholar
- Lanotte P, Watt S, Mereghetti L, Dartiguelongue N, Rastegar-Lari A, Goudeau A, Quentin R: Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J Med Microbiol. 2004, 53: 73-81. 10.1099/jmm.0.05324-0.PubMedView ArticleGoogle Scholar
- Khan NH, Ishii Y, Kimata-Kino N, Esaki H, Nishino T, Nishimura M, Kogure K: Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates. Microbial Ecology. 2007, 53: 173-186. 10.1007/s00248-006-9059-3.PubMedView ArticleGoogle Scholar
- Kurz CL, Chauvet S, Andrès E, Aurouze M, Vallet I, Michel GP, Uh M, Celli J, Filloux A, De Bentzmann S, et al: Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J. 2003, 22: 1451-1460. 10.1093/emboj/cdg159.PubMed CentralPubMedView ArticleGoogle Scholar
- Coenye T, Vandamme P: Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol. 2003, 5: 719-729. 10.1046/j.1462-2920.2003.00471.x.PubMedView ArticleGoogle Scholar
- Tabacchioni S, Ferri L, Manno G, Mentasti M, Cocchi P, Campana S, Ravenni N, Taccetti G, Dalmastri C, Chiarini L, et al: Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complex. FEMS Microbiol Lett. 2008, 281: 175-182. 10.1111/j.1574-6968.2008.01105.x.PubMedView ArticleGoogle Scholar
- Chalupowicz L, Manulis-Sasson S, Itkin M, Sacher A, Sessa G, Barash I: Quorum-sensing system affects gall development incited by Pantoea agglomerans pv. gypsophilae. Mol Plant-Microbe Interact. 2008, 21 (8): 1094-1105. 10.1094/MPMI-21-8-1094.PubMedView ArticleGoogle Scholar
- Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22: 4673-4680. 10.1093/nar/22.22.4673.PubMed CentralPubMedView ArticleGoogle Scholar
- Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007, 24: 1596-1599. 10.1093/molbev/msm092.PubMedView ArticleGoogle Scholar
- Habera L, Smith N, Donahoo R, Lamour K: Use of a single primer to fluorescently label selective amplified fragment length polymorphism reactions. BioTechniques. 2004, 37: 902-904.PubMedGoogle Scholar
- Vos P, Hogers R, Bleeker M, Reijans M, Lee van der T, Hornes M, Frijters A, Pot J, Peleman J, Kuiper M, et al: AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res. 1995, 23: 4407-4414. 10.1093/nar/23.21.4407.PubMed CentralPubMedView ArticleGoogle Scholar
- Zane L, Bargelloni L, Patarnello T: Strategies for microsatellite isolation: a review. Mol Ecol. 2002, 11: 1-16. 10.1046/j.0962-1083.2001.01418.x.PubMedView ArticleGoogle Scholar
- Brady C, Cleenwerck I, Venter SN, Vancanneyt M, Swings J, Coutinho TA: Phylogeny and identification of Pantoea species associated with plants, humans and the natural environment based on multilocus sequence analysis (MLSA). Syst Appl Microbiol. 2008, 31: 447-460. 10.1016/j.syapm.2008.09.004.PubMedView ArticleGoogle Scholar
- Brenner DJ, Fanning GR, Leete Knutson JK, Steigerwalt AG, Krichevsky MI: Attempts to classify Herbicola group-Enterobacter agglomerans strains by deoxyribonucleic acid hybridization and phenotypic tests. Int J Syst Bacteriol. 1984, 34 (1): 45-55.View ArticleGoogle Scholar
- Smits THM, Rezzonico F, Pelludat C, Stockwell VO, Goesmann A, Frey JE, Duffy B: Complete genome sequencing of Pantoea agglomerans strain C9-1. IOBC Bull. 2009, 43: 375-378.Google Scholar
- Brady C, Venter S, Cleenwerck I, Vancanneyt M, Swings J, Coutinho T: A FALFP system for the improved identification of plant-pathogenic and plant-associated species of the genus Pantoea. Syst Appl Microbiol. 2007, 30 (5): 413-417. 10.1016/j.syapm.2007.01.005.PubMedView ArticleGoogle Scholar
- Manulis S, Barash I: Pantoea agglomerans pvs. gypsophilae and betae, recently evolved pathogens?. Mol Plant Pathol. 2003, 4 (5): 307-314. 10.1046/j.1364-3703.2003.00178.x.PubMedView ArticleGoogle Scholar
- Manulis S, Gafni Y, Clark E, Zutra D, Ophir Y, Barash I: Identification of a plasmid DNA probe for detection of Erwinia herbicola pathogenic on Gypsophila paniculata. Phytopathology. 1991, 81: 54-57. 10.1094/Phyto-81-54.View ArticleGoogle Scholar
- Carroll KC, Glanz BD, Borek AP, Burger C, Bhally HS, Henciak S, Flayhart D: Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterobacteriaceae. J Clin Microbiol. 2006, 44 (10): 3506-3509. 10.1128/JCM.00994-06.PubMed CentralPubMedView ArticleGoogle Scholar
- O'Hara CM: Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli. J Clin Microbiol. 2006, 44 (3): 928-933. 10.1128/JCM.44.3.928-933.2006.PubMed CentralPubMedView ArticleGoogle Scholar
- Verdonck L, Mergaert J, Rijckaert C, Swings J, Kersters K, De Ley J: Genus Erwinia: numerical analysis of phenotypic features. Int J Syst Bacteriol. 1987, 37: 4-18.View ArticleGoogle Scholar
- Sanjaq S: Enterobacter sakazakii - Risikoprofil und Untersuchungen zum Nachweis in Säuglingsnahrungen. Ph. D. thesis. 2007, Giessen: Justus-Liebig-UniversitaetGoogle Scholar
- Ewing WH, Fife MA: Enterobacter agglomerans (Beijerinck) comb. nov. (the herbicola-lathyri bacteria). Int J Syst Bacteriol. 1972, 22 (1): 4-11.View ArticleGoogle Scholar
- Mergaert J, Hauben L, Cnockaert MC, Swings J: Reclassification of non-pigmented Erwinia herbicola strains from trees as Erwinia billingiae sp. nov. Int J Syst Bacteriol. 1999, 49: 377-383.PubMedView ArticleGoogle Scholar
- Tamura K, Sakazaki R, Kosako Y, Yoshizaki E: Leclercia adecarboxylata gen. nov., comb. nov., formerly known as Escherichia adecarboxylata. Curr Microbiol. 1986, 13: 179-184. 10.1007/BF01568943.View ArticleGoogle Scholar
- Beji A, Mergaert J, Gavini F, Izard D, Kersters K, Leclerc H, De Ley J: Subjective synonymy of Erwinia herbicola, Erwinia milletiae, and Enterobacter agglomerans and redefinition of the taxon by genotypic and phenotypic data. Int J Syst Bacteriol. 1988, 38 (1): 77-88.View ArticleGoogle Scholar
- Mergaert J, Verdonck L, Kersters K: Transfer of Erwinia ananas (synonym, Erwinia uredovora) and Erwinia stewartii to the genus Pantoea emend. as Pantoea ananas (Serrano 1928) comb. nov. and Pantoea stewartii (Smith 1898) comb. nov., respectively, and description of Pantoea stewartii subsp. indologenes subsp. nov. Int J Syst Bacteriol. 1993, 43 (1): 162-173.View ArticleGoogle Scholar
- Lind E, Ursing J: Clinical strains of Enterobacter agglomerans (synonyms: Erwinia herbicola, Erwinia milletiae) identified by DNA-DNA-hybridization. Acta path microbiol immunol scand Sect B. 1986, 94: 205-213.Google Scholar
- Grimont PAD, Grimont F, Farmer JJ, Asbury MA: Cedecea davisae gen. nov, sp. nov. and Cedecea lapagei sp. nov, new Enterobacteriaceae from clinical specimens. Int J Syst Bacteriol. 1981, 31: 317-326.View ArticleGoogle Scholar
- Rezzonico F, Defago G, Moenne-Loccoz Y: Comparison of ATPase-encoding type III secretion system hrcN genes in biocontrol fluorescent Pseudomonads and in phytopathogenic proteobacteria. Applied and environmental microbiology. 2004, 70 (9): 5119-5131. 10.1128/AEM.70.9.5119-5131.2004.PubMed CentralPubMedView ArticleGoogle Scholar
- Jin M, Wright SAI, Beer SV, Clardy J: The biosynthetic gene cluster of pantocin A provides insights into biosynthesis and a tool for screening. Angew Chem Int Ed. 2003, 42: 2902-2905. 10.1002/anie.200351054.View ArticleGoogle Scholar
- Beijerinck MW: Cultur des Bacillus radicicola aus den Knollchen. Bot Zeitung. 1888, 46: 740-750.Google Scholar
- Dye DW: A taxonomic study of the genus Erwinia. III. The "herbicola" group. N Z J Sci. 1969, 12: 223-236.Google Scholar
- Graham DC, Hodgkiss W: Identity of gram negative, yellow pigmented, fermentative bacteria isolated from plants and animals. J Appl Bacteriol. 1967, 30: 175-189.PubMedView ArticleGoogle Scholar
- Leliott RA: Genus XII. Erwinia. Winslow, Broadhurst, Buchanan, Krumwiede, Rogers and Smith 1920. Bergey's manual of determinative bacteriology. Edited by: RE B, Gibbons NE. 1974, Baltimore: The Williams & Wilkins Co, 332-359. 8Google Scholar
- Dauga C: Evolution of the gyrB gene and the molecular phylogeny of Enterobacteriaceae: a model molecule for molecular systematic studies. International Journal of Systematic and Evolutionary Microbiology. 2002, 52: 531-547.PubMedView ArticleGoogle Scholar
- Weisburg WG, Barns SM, Pelletier DA, Lane DJ: 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 1991, 173 (2): 697-703.PubMed CentralPubMedGoogle Scholar
- Dotzauer C, Ehrmann MA, Vogel RF: Occurrence and detection of Thermoanaerobacterium and Thermoanaerobacter in canned food. Food Technol Biotechnol. 2002, 40: 21-26.Google Scholar